Cephalexin Dosing for Cellulitis
For adult patients with cellulitis, the recommended dose of cephalexin is 500 mg four times daily (every 6 hours) for 5-7 days. 1, 2
Adult Dosing Regimen
- Standard oral regimen: 500 mg every 6 hours (2 g total daily dose) 1, 3
- Duration: 5 days is typically sufficient if clinical improvement occurs, though treatment may be extended if infection has not adequately improved 1, 3
- For more severe infections, doses up to 4 g daily may be considered 2
Pediatric Dosing Regimen
- Standard dose: 75-100 mg/kg/day divided into 3-4 doses 2
- For typical skin infections: 25-50 mg/kg/day divided into 4 doses 2
- For severe infections, dosage may be doubled 2
Clinical Decision Algorithm
Assess severity and type of cellulitis:
Determine appropriate duration:
Consider adjunctive measures:
Evidence Strength and Considerations
- MRSA is an unusual cause of typical cellulitis - β-lactam monotherapy with cephalexin is appropriate in the absence of abscess, ulcer, or purulent drainage 1, 3
- Recent randomized trials show that adding trimethoprim-sulfamethoxazole (for MRSA coverage) to cephalexin does not significantly improve outcomes for uncomplicated cellulitis 4, 5
- A recent pilot study suggests high-dose cephalexin (1000 mg four times daily) may reduce treatment failure compared to standard dosing (500 mg four times daily), though with more minor adverse effects 6
- Adding anti-inflammatory therapy (such as ibuprofen) to antibiotic treatment may hasten resolution of cellulitis-related inflammation 7
Common Pitfalls to Avoid
- Don't automatically add MRSA coverage for typical non-purulent cellulitis without specific risk factors for MRSA 1, 3
- Don't extend treatment unnecessarily beyond 5-7 days if clinical improvement has occurred 1, 3
- Don't overlook examining interdigital toe spaces in lower-extremity cellulitis, as treating fissuring or maceration may reduce recurrence 1
- Don't forget to consider hospitalization if there is concern for deeper infection, poor adherence to therapy, immunocompromise, or if outpatient treatment is failing 1
Special Situations
- For cellulitis associated with penetrating trauma, evidence of MRSA infection elsewhere, nasal colonization with MRSA, or injection drug use: consider adding MRSA coverage 1, 3
- For recurrent cellulitis: address predisposing factors and consider prophylactic antibiotics for patients with 3-4 episodes per year 3
- For penicillin-allergic patients (except those with immediate hypersensitivity reactions), cephalexin remains an option 1